Skip to content
Elezanumab
Elezanumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against repulsive guidance molecule A.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple sclerosisD009103EFO_0003885G3522———4
Ischemic strokeD000083242—1——12
Spinal cord injuriesD013119EFO_1001919—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameELEZANUMAB
INNelezanumab
Description
Elezanumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against repulsive guidance molecule A.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL4297743
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDSK1LVT23A1 (ChemIDplus, GSRS)
Target
Agency Approved
RGMA
RGMA
Organism
Homo sapiens
Gene name
RGMA
Gene synonyms
RGM
NCBI Gene ID
56963
Protein name
repulsive guidance molecule A
Protein synonyms
repulsive guidance molecule family member a, RGM domain family member A, RGM domain family, member A
Uniprot ID
Q96B86
Mouse ortholog
Rgma (244058)
repulsive guidance molecule A (Q8CIH6)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 27 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details